Intratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy.

Emerging evidence reveals that intratumoral microbial (ITM) communities within the tumor immune microenvironment (TIME) critically influence tumor progression and immunotherapy response. Studies have shown that resident bacteria within tumors, such a…

Preview only. Read the full abstract at the source